title: Antisulfatide antibodies in neuropathy: clinical and electrophysiologic correlates.
abstract: OBJECTIVE
  To investigate the clinical and electrophysiologic characteristics of the neuropathy associated with elevated serum antisulfatide antibodies.
  
  
  METHODS
  Clinical, electrophysiologic, morphologic, and laboratory data of 25 patients with significantly elevated (>25,600) antisulfatide antibodies were reviewed.
  
  
  RESULTS
  Four groups were distinguished based on clinical and electrophysiologic data: Group 1, eight patients with predominantly small fiber sensory neuropathy (32%); Group 2, five patients with mixed large and small fiber sensory neuropathy (20%); Group 3, seven patients with axonal sensorimotor neuropathy (28%); and Group 4, three patients with demyelinating sensorimotor neuropathy (12%). One additional patient had mononeuritis multiplex and one had ALS. An immunoglobulin M (IgM) monoclonal gammopathy was found in 30% of the patients tested, but not in any of the Group 1 patients with small fiber sensory neuropathy. Serum IgM level was elevated in 12 patients, of whom six had a concomitant monoclonal gammopathy. Morphologic studies in five patients showed predominantly axonal degeneration, with three of the patients also exhibiting additional features of demyelination.
  
  
  CONCLUSIONS
  Antisulfatide antibodies are associated with several subtypes of peripheral neuropathy. Predominantly sensory or sensorimotor axonal neuropathies are most common in this series, with the sensory component either small fiber or mixed fiber type. A smaller demyelinating group indistinguishable from patients with chronic inflammatory demyelinating polyradiculopathy was also seen. One third of patients had a concomitant IgM monoclonal gammopathy, and approximately one half had elevated serum IgM.
authors.affiliation: College of Physicians and Surgeons, Columbia Presbyterian Medical Center, New York, NY, USA.
authors.forename: R
authors.initials: R
authors.lastname: Dabby
authors.forename: L H
authors.initials: LH
authors.lastname: Weimer
authors.forename: A P
authors.initials: AP
authors.lastname: Hays
authors.forename: M
authors.initials: M
authors.lastname: Olarte
authors.forename: N
authors.initials: N
authors.lastname: Latov
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001323:Autoantibodies / Q000097:blood*; D001369:Axons / Q000473:pathology / Q000648:ultrastructure; D004576:Electromyography; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009431:Neural Conduction; D010146:Pain / Q000209:etiology; D010523:Peripheral Nervous System Diseases / Q000175:diagnosis* / Q000276:immunology*; D020277:Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / Q000175:diagnosis / Q000276:immunology; D011597:Psychomotor Performance; D013433:Sulfoglycosphingolipids / Q000276:immunology*; D013497:Sural Nerve / Q000473:pathology / Q000648:ultrastructure
chemical_list: D001323:Autoantibodies; D013433:Sulfoglycosphingolipids